10-06-2022 11:34 via wallstreet-online.de

Bavarian Nordic Raises Outlook Again After Another U.S. Smallpox, Monkeypox Vaccine Orders

(PLX AI) – Bavarian Nordic Outlook FY revenue DKK 1,800-2,000 million, up from DKK 1,400-1,600 million.Outlook FY EBITDA DKK -900 to -700 million, up from DKK -1,100 to -900 millionBavarian Nordic Receives an Additional Order for JYNNEOS Smallpox …
Weiterlesen »